Arguseye
Founded 2017 · 25 employees on LinkedIn · 2 known investors
Find your way into Arguseye
Sign up to see every warm intro you have to Arguseye
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arguseye team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing. Its patented Auga platform combines sensor hardware, sensor chips, and software to track critical quality attributes and process parameters, including in-line detection of antibody aggregates and fragments during purification.
Investors · 2
EIR Ventureslisted by EIR VenturesStockholm
How we know: EIR Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Voima VenturesreportedHelsinki · $216K – $3.2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Arguseye do?
- ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing. Its patented Auga platform combines sensor hardware, sensor chips, and software to track critical quality attributes and process parameters, including in-line detection of antibody aggregates and fragments during purification.
- Who are Arguseye's investors?
- Arguseye's investors include EIR Ventures, Voima Ventures.

